[EN] NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY ON PROSTAGLANDIN E2 RECEPTOR AND USES THEREOF<br/>[FR] NOUVEAUX COMPOSÉS AYANT UNE ACTIVITÉ INHIBITRICE SUR LE RÉCEPTEUR DE LA PROSTAGLANDINE E2 ET LEURS UTILISATIONS
申请人:KANAPH THERAPEUTICS INC
公开号:WO2022039563A1
公开(公告)日:2022-02-24
The present application relates to a novel compound having inhibitory activity on prostaglandin E2 receptor and uses thereof, and provides a compound represented by formula I, a solvate, stereoisomer or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and a method of using the same.
本申请涉及一种对前列腺素E2受体具有抑制活性的新化合物及其用途,提供了一种由式I代表的化合物,其溶剂化物、立体异构体或药用可接受的盐,包括该化合物的药物组合物,以及使用该化合物的方法。